Baxter and Halozyme resubmit HyQvia to FDA
Insights - If at first you don’t succeed, try again. Baxter Healthcare (BAX) and Halozyme Therapeutics, Inc. (HALO) submitted an amended biologics license application (BLA) to the … Continue Reading
Read now